Curable. Inc. (XKON: 086460)

Market Cap	9.32B
Revenue	n/a
Net Income	n/a
Shares Out	2.94M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	394
Open	3,270.00
Previous Close	2,930.00
Day's Range	2,495.00 - 3,270.00
52-Week Range	1,890.00 - 8,240.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Curable.

Curable. Inc. provides single nucleotide polymorphism (SNP) research and analysis services in South Korea. The company offers various services, such as genome analyzer; and sequencing and re-sequencing, immunoprecipitate sequencing, small RNA discovery and analysis, and digital gene expression profiling services. It also provides SNP genotyping services; SNP discovery services; and microsatellites typing, DNA sequencing, bio-informatics, gene identification, and statistical analysis services. The company serves pharmaceutical companies. The com...

• Industry: Commercial Physical and Biological Research
• Founded: 2000
• Employees: 16
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 086460